Influence of ethinyl estradiol on C1s inhibitor: a new etiopathogenetic mechanism of angioedema. Case report.
Bettoni
L
L
Servizio Immunotrasfusionale, Ospedale di Gavardo, via Gosa 73 25085, Gavardo (BS).
D000328:Adult; D000799:Angioedema / Q000209:etiology* / Q000276:immunology; D001323:Autoantibodies / Q000096:biosynthesis / Q000276:immunology*; D003174:Complement C1 Inactivator Proteins; D050718:Complement C1 Inhibitor Protein; D003169:Complement Inactivator Proteins / Q000172:deficiency / Q000276:immunology; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects* / Q000494:pharmacology; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects* / Q000494:pharmacology; D017449:Dermatitis, Allergic Contact / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004997:Ethinyl Estradiol / Q000009:adverse effects* / Q000494:pharmacology; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000008:administration & dosage; D015843:Serpins / Q000172:deficiency / Q000276:immunology
D001323:Autoantibodies; D003174:Complement C1 Inactivator Proteins; D050718:Complement C1 Inhibitor Protein; D003169:Complement Inactivator Proteins; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; C469952:SERPING1 protein, human; D015843:Serpins; D004997:Ethinyl Estradiol; D016912:Levonorgestrel